Abrdn Life Sciences Investors (NYSE:HQL) Plans Quarterly Dividend of $0.50

Abrdn Life Sciences Investors (NYSE:HQL) announced a quarterly dividend on Wednesday, November 13th,Wall Street Journal reports. Investors of record on Thursday, November 21st will be given a dividend of 0.50 per share on Friday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 13.61%. The ex-dividend date of this dividend is Thursday, November 21st. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

Abrdn Life Sciences Investors Price Performance

NYSE HQL traded down $0.05 on Thursday, hitting $14.69. 12,829 shares of the company were exchanged, compared to its average volume of 91,761. Abrdn Life Sciences Investors has a twelve month low of $11.62 and a twelve month high of $15.90. The company’s 50 day moving average price is $15.03 and its 200-day moving average price is $14.64.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.